Risk mitigation in academic drug discovery

Expert Opin Drug Discov. 2016;11(4):333-6. doi: 10.1517/17460441.2016.1152257. Epub 2016 Mar 3.

Authors

Bernhard Ellinger¹, Philip Gribbon¹

Affiliation

¹ a Department ScreeningPort , Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME, ScreeningPort , Hamburg , Germany.

PMID: 26894865
DOI: 10.1517/17460441.2016.1152257

No abstract available

Publication types

Editorial

MeSH terms

Drug Discovery / methods*
Drug Industry / methods*
Humans
Risk Management / methods*